Ao Zhang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Cell Cycle Arrest

Reactive Oxygen Species

Coronavirus Disease

Signaling Pathway

Top Venues

Nature communications

Cancer cell international

This page only lists publications with an associated author ORCID identifier.

Publications

Junying Wang, Wenting Lu, Jerry Zhang, Yong Du, Mingli Fang, Ao Zhang, Gabriel Sungcad, Samantha Chon, Junji Xing
Loss of TRIM29 mitigates viral myocarditis by attenuating PERK-driven ER stress response in male mice. Nature communications 15 (1) (2024)
Junying Wang, Wenting Lu, Jerry Zhang, Yong Du, Mingli Fang, Ao Zhang, Gabriel Sungcad, Samantha Chon, Junji Xing
Loss of TRIM29 mitigates viral myocarditis by attenuating PERK-driven ER stress response in male mice. Nature communications 15 (1) (2024)
Junying Wang, Wenting Lu, Jerry Zhang, Yong Du, Mingli Fang, Ao Zhang, Gabriel Sungcad, Samantha Chon, Junji Xing
Loss of TRIM29 mitigates viral myocarditis by attenuating PERK-driven ER stress response in male mice. Nature communications 15 (1) (2024)
Junying Wang, Wenting Lu, Jerry Zhang, Yong Du, Mingli Fang, Ao Zhang, Gabriel Sungcad, Samantha Chon, Junji Xing
Loss of TRIM29 mitigates viral myocarditis by attenuating PERK-driven ER stress response in male mice. Nature communications 15 (1) (2024)
Xiaobin Wu, Runkun Han, Yanping Zhong, Nuoqing Weng, Ao Zhang
Correction to: Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma. Cancer cell international 21 (1) (2021)
Xianbin Wu, Runkun Han, Yanping Zhong, Nuoqing Weng, Ao Zhang
Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma. Cancer cell international 21 (1) (2021)